Logo image of SIGA

SIGA TECHNOLOGIES INC (SIGA) Stock News

NASDAQ:SIGA - Nasdaq - US8269171067 - Common Stock - Currency: USD

6.065  +0.08 (+1.25%)

After market: 6.065 0 (0%)

SIGA Latest News, Press Relases and Analysis

News Image
a month ago - Yahoo Finance

Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best pharma stocks to buy for long term growth. U.S. Pharma Turns to China for Drug Deals With big American pharmaceutical […]

Mentions: AZN NFLX TSLA BCDA ...

News Image
a month ago - SIGA Technologies Inc.

SIGA Declares Special Cash Dividend of $0.60 Per Share

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced...

News Image
2 months ago - Zacks Investment Research

Siga Technologies Inc. (SIGA) Stock Sinks As Market Gains: What You Should Know

Siga Technologies Inc. (SIGA) closed at $5.48 in the latest trading session, marking a -1.26% move from the prior day.

News Image
2 months ago - SIGA Technologies Inc.

SIGA Appoints Retired General John M. Keane to its Board of Directors

General Keane brings significant expertise in national security and biodefense preparedness...

News Image
2 months ago - SIGA Technologies Inc.

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Increased Product Sales to $133 Million in 2024Generated Pre-tax Operating Income and Net Income of $70 Million and $59 Million, Respectively, in...

News Image
18 days ago - Zacks Investment Research

Siga Technologies Inc. (SIGA) Stock Declines While Market Improves: Some Information for Investors

In the most recent trading session, Siga Technologies Inc. (SIGA) closed at $5.43, indicating a -1.63% shift from the previous trading day.

News Image
19 days ago - SIGA Technologies Inc.

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that...

News Image
24 days ago - Zacks Investment Research

Here's Why Siga Technologies Inc. (SIGA) Gained But Lagged the Market Today

Siga Technologies Inc. (SIGA) reachead $6.51 at the closing of the latest trading day, reflecting a +0.39% change compared to its last close.

News Image
a month ago - Zacks Investment Research

Siga Technologies Inc. (SIGA) Outperforms Broader Market: What You Need to Know

The latest trading day saw Siga Technologies Inc. (SIGA) settling at $6.25, representing a +1.96% change from its previous close.

News Image
a month ago - Zacks Investment Research

Siga Technologies Inc. (SIGA) Stock Moves -1.82%: What You Should Know

In the latest trading session, Siga Technologies Inc. (SIGA) closed at $5.93, marking a -1.82% move from the previous day.

News Image
2 months ago - Benzinga

NIH Trial Finds Tecovirimat Ineffective As Monotherapy For Mpox

SIGA Technologies’ (NASDAQ:SIGA) antiviral drug tecovirimat, when used without other treatments, did not reduce the time for clade ...

News Image
3 months ago - SIGA Technologies Inc.

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced...

News Image
5 months ago - SIGA Technologies Inc.

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno...

News Image
5 months ago - SIGA Technologies Inc.

Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced

Interim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy...

News Image
7 months ago - SIGA Technologies Inc.

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced...

News Image
7 months ago - Wolf Haldenstein Adler Freeman & Herz LLP

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...

News Image
7 months ago - SIGA Technologies Inc.

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...

News Image
7 months ago - SIGA Technologies Inc.

SIGA Announces Agreement to Supply TPOXX® in Morocco

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) --  SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...

News Image
8 months ago - Wolf Haldenstein Adler Freeman & Herz LLP

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...

News Image
8 months ago - Wolf Haldenstein Adler Freeman & Herz LLP

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...